AI technology is central to the operations of Recursion Pharmaceuticals.
5 reports, 2 independent
Updated Aug 4
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 5
- Developments
- 4
- Repetition
- 40%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AI technology is central to the operations of Recursion Pharmaceuticals.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Recursion announces its global presence, including offices in Montréal, London, and Oxford, and plans a live stream on LinkedIn.Sub-event
Recursion Pharmaceuticals utilizes AI as a core component of its operational processes.1 source
Recursion establishes global office locations in Montréal, London, and Oxford area.1 source
- Nvidia's support catalyzes Recursion's expansion.
Keep exploring
The entities involved
-
Recursion (United States)
company in Salt Lake City, United States
Related events
Coverage
Newest first; wire copies grouped- Motley FoolIf You'd Invested $1,000 in Recursion Pharmaceuticals 4 Years Ago, Here's How Much You'd Have Today Recursion Pharmaceuticals has significantly lagged the market since its 2021 IPO. The company's pot
- GlobeNewswireRecursion to Participate in Upcoming Investor Conferences Salt Lake City, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radi
- Motley Fool1 Reason to Buy This Beaten-Down Artificial Intelligence (AI) Stock, and 2 Reasons to Sell Recursion could be on the verge of transforming the drug development process. However, the company has yet t
- Unknown outlet